skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Wiley Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
FXR an emerging therapeutic target for the treatment of atherosclerosis
FXR an emerging therapeutic target for the treatment of atherosclerosis
Material Type:
Article 		Add to My Research

FXR an emerging therapeutic target for the treatment of atherosclerosis

Journal of cellular and molecular medicine, 2010-01, Vol.14 (1‐2), p.79-92 [Peer Reviewed Journal]

2009 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd ;Copyright Blackwell Publishing Ltd. Jan/Feb 2010 ;Copyright John Wiley & Sons, Inc. Jan 2010 ;2009 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd 2009 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/j.1582-4934.2009.00997.x ;PMID: 20041971

Digital Resources/Online E-Resources

Citations Cited by
2
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease
Material Type:
Article 		Add to My Research

Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease

Journal of the American Heart Association, 2023-12, Vol.12 (23), p.e031241-e031241 [Peer Reviewed Journal]

2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.123.031241 ;PMID: 37996988

Full text available

Citations Cited by
3
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice
Material Type:
Article 		Add to My Research

Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice

British journal of pharmacology, 2013-01, Vol.168 (1), p.225-237 [Peer Reviewed Journal]

2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society ;2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society. ;British Journal of Pharmacology © 2013 The British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2012.02128.x ;PMID: 22881598

Full text available

Citations Cited by
4
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
Material Type:
Article 		Add to My Research

Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling

The FASEB journal, 2022-01, Vol.36 (1), p.e22060-n/a [Peer Reviewed Journal]

2021 The Authors. published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology. ;2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology. ;ISSN: 0892-6638 ;EISSN: 1530-6860 ;DOI: 10.1096/fj.202101397R ;PMID: 34862975

Full text available

Citations Cited by
5
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling
Material Type:
Article 		Add to My Research

TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling

British journal of pharmacology, 2023-01, Vol.180 (2), p.235-251 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2022 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15960 ;PMID: 36168728

Full text available

Citations Cited by
6
Activation of the farnesoid‐X receptor protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs in mice
Activation of the farnesoid‐X receptor protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs in mice
Material Type:
Article 		Add to My Research

Activation of the farnesoid‐X receptor protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs in mice

British journal of pharmacology, 2011-12, Vol.164 (8), p.1929-1938 [Peer Reviewed Journal]

2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society ;2015 INIST-CNRS ;2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society. ;British Journal of Pharmacology © 2011 The British Pharmacological Society 2011 ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2011.01481.x ;PMID: 21564085 ;CODEN: BJPCBM

Full text available

Citations Cited by
7
Activation of the bile acid receptor GPBAR 1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice
Activation of the bile acid receptor GPBAR 1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice
Material Type:
Article 		Add to My Research

Activation of the bile acid receptor GPBAR 1 protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs and aspirin in mice

British journal of pharmacology, 2013-01, Vol.168 (1), p.225-237 [Peer Reviewed Journal]

ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2012.02128.x

Full text available

Citations Cited by
8
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by nonsteroidal anti-inflammatory drugs and aspirin in mice
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by nonsteroidal anti-inflammatory drugs and aspirin in mice
Material Type:
Article 		Add to My Research

Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by nonsteroidal anti-inflammatory drugs and aspirin in mice

British journal of pharmacology, 2012-12, Vol.168 (1), p.225-237 [Peer Reviewed Journal]

British Journal of Pharmacology © 2013 The British Pharmacological Society 2013 ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2012.02128.x ;PMID: 22881598

Full text available

Citations Cited by
9
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice: FXR and NSAID gastro-enteropathy
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice: FXR and NSAID gastro-enteropathy
Material Type:
Article 		Add to My Research

Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice: FXR and NSAID gastro-enteropathy

British journal of pharmacology, 2011-12, Vol.164 (8), p.1929-1938 [Peer Reviewed Journal]

ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/j.1476-5381.2011.01481.x

Full text available

Citations Cited by
10
Liver delivery of NO by NCX‐1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice 
THIS ARTICLE HAS BEEN RETRACTED
Liver delivery of NO by NCX‐1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice 
THIS ARTICLE HAS BEEN RETRACTED
Material Type:
Article 		Add to My Research

Liver delivery of NO by NCX‐1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice 
THIS ARTICLE HAS BEEN RETRACTED

British journal of pharmacology, 2009-02, Vol.143 (1), p.33-42 [Peer Reviewed Journal]

2004 British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0705780

Full text available

Citations Cited by
11
Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin
Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin
Material Type:
Article 		Add to My Research

Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin

British journal of pharmacology, 2003-08, Vol.139 (7), p.1351-1359 [Peer Reviewed Journal]

2003 British Pharmacological Society ;2004 INIST-CNRS ;Copyright Nature Publishing Group Aug 2003 ;Copyright 2003, Nature Publishing Group 2003 Nature Publishing Group ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0705356 ;PMID: 12890715 ;CODEN: BJPCBM

Full text available

Citations Cited by
12
A NO‐releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway 
THIS ARTICLE HAS BEEN RETRACTED
A NO‐releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway 
THIS ARTICLE HAS BEEN RETRACTED
Material Type:
Article 		Add to My Research

A NO‐releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway 
THIS ARTICLE HAS BEEN RETRACTED

British journal of pharmacology, 2009-02, Vol.135 (3), p.589-599 [Peer Reviewed Journal]

2002 British Pharmacological Society ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0704500

Full text available

Citations Cited by
13
Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice
Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice
Material Type:
Article 		Add to My Research

Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice

British journal of pharmacology, 2004-09, Vol.143 (1), p.33-42 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2004 ;Copyright 2004, Nature Publishing Group 2004 Nature Publishing Group ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0705780 ;PMID: 15345658

Full text available

Citations Cited by
14
NO‐naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis
NO‐naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis
Material Type:
Article 		Add to My Research

NO‐naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis

British journal of pharmacology, 2000-07, Vol.130 (6), p.1399-1405 [Peer Reviewed Journal]

2000 British Pharmacological Society ;2000 INIST-CNRS ;Copyright Nature Publishing Group Jul 2000 ;Copyright 2000, Nature Publishing Group 2000 Nature Publishing Group ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0703449 ;PMID: 10903982 ;CODEN: BJPCBM

Full text available

Citations Cited by
15
21‐NO‐prednisolone is a novel nitric oxide‐releasing derivative of prednisolone with enhanced anti‐inflammatory properties
21‐NO‐prednisolone is a novel nitric oxide‐releasing derivative of prednisolone with enhanced anti‐inflammatory properties
Material Type:
Article 		Add to My Research

21‐NO‐prednisolone is a novel nitric oxide‐releasing derivative of prednisolone with enhanced anti‐inflammatory properties

British journal of pharmacology, 2000-12, Vol.131 (7), p.1345-1354 [Peer Reviewed Journal]

2000 British Pharmacological Society ;2001 INIST-CNRS ;Copyright Nature Publishing Group Dec 2000 ;Copyright 2000, Nature Publishing Group 2000 Nature Publishing Group ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0703704 ;PMID: 11090106 ;CODEN: BJPCBM

Full text available

Citations Cited by
16
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway
Material Type:
Article 		Add to My Research

A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway

British journal of pharmacology, 2002-02, Vol.135 (3), p.589-599 [Peer Reviewed Journal]

2002 INIST-CNRS ;Copyright Nature Publishing Group Feb 2002 ;Copyright 2002, Nature Publishing Group 2002 Nature Publishing Group ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1038/sj.bjp.0704500 ;PMID: 11834606 ;CODEN: BJPCBM

Full text available

Citations Cited by
17
Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Commentary
Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Commentary
Material Type:
Article 		Add to My Research

Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Commentary

British journal of pharmacology, 2004, Vol.143 (1), p.33-2 [Peer Reviewed Journal]

2004 INIST-CNRS ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;CODEN: BJPCBM

Full text available

Citations Cited by
18
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells
Material Type:
Article 		Add to My Research

Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells

European journal of immunology, 1995-10, Vol.25 (10), p.2932-2939 [Peer Reviewed Journal]

Copyright © 1995 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;ISSN: 0014-2980 ;EISSN: 1521-4141 ;DOI: 10.1002/eji.1830251033 ;PMID: 7589094

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait